AlphAIAlphAI — Financial news for AI agents
financial-news.co.ukOCT 62 min read$OPCH

CD&R, McKesson agree $5.8bn buyout of Option Care Health

CD&R and McKesson (MCK) agreed to acquire Option Care Health (OPCH) for $32.05 per share, valuing it at $5.8bn. Option Care shares rose 9.19% on the news, trading at a premium of 37-43% over recent lows. CD&R will hold majority ownership, while McKesson takes a minority stake, taking Option Care private.

Original reporting
financial-news.co.uk
Published Oct 6, 2026, 1:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 3:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
CD&R, McKesson agree $5.8bn buyout of Option Care Health — source image
Source · financial-news.co.uk
Decision brief

The 30-second read

$OPCHBullishHigh
01

Why it matters

The deal provides a clear premium to Option Care shareholders, creating short‑term arbitrage opportunities, while McKesson gains a strategic foothold in infusion services.

02

Market read

First‑report M&A of mid‑cap size, immediate price reaction, and sector consolidation implications.

03

What to watch

Potential regulatory clearance delays and the impact of elevated borrowing costs on CD&R's leverage.

Relevance 9/10Novelty 9/10Timing: today

Background

The article reports the first public disclosure of a $5.8 bn take‑private transaction for Option Care Health, involving private equity firm CD&R and distributor McKesson.

Company-level read

Ticker impact

$OPCHBullishHigh confidence
Context

Option Care Health announced a definitive agreement to be taken private at $32.05 per share, valuing the company at about $5.8 bn, causing the stock to jump 9.2% on the day.

Expected impact

likely upward pressure as the premium is locked in, but upside limited after the announcement

Evidence & confidence

The deal price is a clear premium to recent trading ranges; arbitrage opportunities narrow quickly.

$MCKNeutralMedium confidence
Context

McKesson Corp. disclosed a minority stake purchase in the Option Care buyout, joining CD&R as a co‑buyer.

Expected impact

slight positive bias as investors view the strategic expansion, but no immediate price move expected

Evidence & confidence

McKesson's share price typically reacts modestly to acquisition stakes; the transaction size is small relative to its market cap.

Market effects

Sector

Healthcare services consolidation may lift peers in infusion therapy and specialty care.

Regional

U.S. healthcare sector sees modest bullish pressure from the deal.

Global

Limited; primarily a U.S. domestic M&A event.

Counterpoint

What could challenge this read

If the premium is already reflected, the buyout could face financing strain in a high‑rate environment, pressuring the stock.

Key entities

  • Company
    Option Care Health

    Home and alternate‑site infusion therapy provider being taken private.

  • Company
    McKesson Corp.

    Healthcare distributor acquiring a minority stake in the buyout.

  • Private Equity
    CD&R

    Lead private‑equity sponsor acquiring majority control.

Read at source← All news

StoryCD&R and McKesson agree to acquire Option Care Health

Also covered by

4 outlets

Related articles

OCT 30
$BTSGHighAI 9/10

BrightSpring Soars 12% on Q3 Beat and Raised 2026 Guidance as Adjusted EBITDA Jumps 42%

BrightSpring Health Services (BTSG) stock rose 12% after Q3 earnings beat estimates, with revenue up 26% to $4.21B and adjusted EBITDA up 42% to $228M. The company raised its 2026 guidance. Gross profit per script increased 27%, and home health census grew 58% due to acquisitions from UnitedHealth's Amedisys and LHC Group. Option Care Health (OPCH) and CVS Health (CVS) report next week, which may indicate if BrightSpring's pricing gains are industry-wide.

finance.yahoo.com6 min
OCT 27
$MCKLow

Built and Bred

McKesson (MCK) will invest $179M in a 330,000 sq. ft. regional distribution center in Moore, Oklahoma, creating 200+ jobs. The site's location, readiness, and regional coordination influenced the decision, according to the company.

citylifestyle.com2 min
OCT 10
$OPCHMed

Key deals this week: Option Care Health, PTC, Energy Transfer and more

Service Properties Trust (SSVC) received a $2.0B acquisition offer from TKO LLC. Viatris (VTRS) agreed to buy Pacira BioSciences (PCRX) for $1.65B. Option Care Health (OPCH) surged 34% after a $5.8B acquisition deal with CD&R and McKesson (MCK). Energy Transfer (ET) will acquire Vaquero Midstream for $2.625B. Emera (EMA) and Canadian Utilities (CDUAF) agreed to a $10B merger. Cenovus Energy (CVE) will acquire Athabasca Oil (ATHOF) for ~$5.7B.

tradingview.com1 min
OCT 10
$OPCHHighAI 9/10

Option Care Health Sold for $5.8B in CD&R-McKesson Deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson (MCK) for $5.8B, or $32.05 per share, a 37% premium. The deal, expected to close in 2027, values the company at $5.8B. Option Care Health will operate independently post-acquisition. The company reported $5.6B in 2025 revenue and $207.6M in net income, with modest growth in 2026. The acquisition aligns with McKesson's strategy to expand access to innovative therapies.

hoodline.com2 min
OCT 9
$MCKHighAI 9/10

McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?

McKesson (MCK) is acquiring Option Care Health (OPCH) for $5.8B, including debt, at $32.05 per share, a 37% premium. McKesson and private equity firm CD&R will own 49% and 51% respectively. The deal expands McKesson's specialty healthcare services. McKesson's Q1 2027 revenue was $105.4B, beating estimates, with adjusted EPS up 20% YoY to $9.93. The company raised its fiscal 2027 adjusted EPS guidance to $44.20-$45.00.

finance.yahoo.com2 min